chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got both shots, but got shingles\ suspected vaccination failure; got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got both Shingles shot but got shingles anyway. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Arthralgia, NauseaVomiting, chills, fatigue, restless muscles Narrative:
3/06/08 - wrist and hand warm yesterday last pm started to swell and painful.  No soreness at vaccination site.  3/07/08 Painful this date right hand and wrist with shooting pain up to right elbow.  Continues to be swollen - no heat or redness noted.  No soreness, redness, or swelling at vaccination site referred to physician.
low grade fever started 6/10/23 and developed rash starting 6/12/2023
Mother called office next day.  Approximately 1-1.5 hours after immunization given, raised rash on neck, back, flank, thighs.  Nothing noted at immunization sites.  Mother gave Benadryl with rash vanishing later in evening and no recurrence.
High fever 104, "talking out of his head", sore throat, swollen glands in neck.  Mother to take to Dr. today.
t admitted 10/25 from mediastinoscopy  in prep for cardiac cath or TAVR; 10/29 to periop for a thoracic lobectomy  Patient was intubated and extubated day of surgery (10/29 and a chest tube removed on 10/30. Asymptomatic patient tested for discharge to SAR
I got a large stinging red rash on my right arm at the injection site that lasted several days, but didn?t appear until a week later after the injection.
prolonged crying episode extending from 7-10hr p/vax given; no convuls activity, no limp episode to now; exp emesis & diarrhea;
Patient discovered lesions on his chest, also noted increased discomfort, tenderness in axillary area of extremity smallpox vaccine received in 10 days ago.
m injection site was a little tender; charlie horse in upper right thigh/charlie horse in part of inner leg; chest started tightening up a little bit; chest pain; could hardly walk; nagging headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (m injection site was a little tender), MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain) and GAIT INABILITY (could hardly walk) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included HYDRALAZINE, AMLODIPINE, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and UBIDECARENONE (COQ) for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain), GAIT INABILITY (could hardly walk) and HEADACHE (nagging headache). On an unknown date, the patient experienced INJECTION SITE PAIN (m injection site was a little tender). On 07-Feb-2021, MUSCLE SPASMS (charlie horse in upper right thigh/charlie horse in part of inner leg), CHEST DISCOMFORT (chest started tightening up a little bit), CHEST PAIN (chest pain), GAIT INABILITY (could hardly walk) and HEADACHE (nagging headache) had resolved. At the time of the report, INJECTION SITE PAIN (m injection site was a little tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
No additional AE/PQC reported.; improperly stored; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided.  On 16-DEC-2020, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot # T015598, expiration date 02-NOV-2021, (exact dose, injection site and route of administration were not reported) for prophylaxis.  Administered dose of vaccine experienced the temperature excursion of 20.5 degrees Fahrenheit for 1 hour and 54 minutes. The digital data logger was involved in recording the temperature excursion details. Administered dose of vaccine experienced the previous temperature excursion of 6 to 14 (12.3) degrees Fahrenheit for 23 hours. There was no additional adverse events reported.
left me a really sore arm; redness; This case was reported by a other health professional and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles (mild case).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and erythema of extremities. On an unknown date, the outcome of the pain in arm and erythema of extremities were recovered/resolved.   It was unknown if the reporter considered the pain in arm and erythema of extremities to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received vaccine and had sore arm for weeks and redness.  This case has been linked with case US2020AMR097354, reported by same reporter.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient were not reported. On 25-APR-2016 the patient was vaccinated with a dose of improperly stored RECOMBIVAX HB (lot # L038018, expiration date: 13-SEP-2017) (dose and route unspecified). Other suspect and concomitant therapies were not reported. No adverse effect reported. The RECOMBIVAX HB was exposed to 49.7 degree Fahrenheit for 1 hour and 45 minutes; there was no previous temperature excursion reported. This is one of several reports received from the same source. Additional information has been requested.
Hives that were itchy, I?m on day 4 of hives. Seems to be dermatographia. Currently have an appointment with dermatologist.
I was diagnosed with possible Meniere?s Disease 2 years ago.  The symptoms have been well-controlled with treatment for 1.5 years. I have not had episodes of Meniere?s for the previous 1.5 years. 6-8 hours after receiving the second Moderna vaccine, I suddenly started having severe attacks of Meniere?s. 3 episodes that day, and a total of 24 episodes in 2.5 weeks after receiving the vaccine. I am still currently having moderate to severe episodes. No recent changes in diet, medications, lifestyle, or anything else that could contribute to it.
(Vaccine at 5pm 1/12/21) That night, 2am on 1/13/21, a fever of 101 developed. At 7am that morning (still 1/13) fever of 101, chills, rash on injection site, vomiting, diarrhea, and 2 syncope episodes (unconscious 1-2 minutes each time).  Symptoms were gone by late evening (1/13), and completely gone by the next day (1/14).   Tylenol and flu & cold medication given throughout the time of the fever.
9am- dizziness and nauseous  10:30am-12:00pm- vomiting, dizziness, fatigue 12:00pm-5:00pm- fatigue, dizziness, nausea  5:00pm-5:00am- fever ranging from 101.5-102, body aches, dizziness, fatigue
Diarrhea: 4-6 times a day.   Today is the third day, I'm still suffering from it.
2-3 blisters on body & some on face & arms;tx Atarax 3/4tsp q 8hrs;Caladryl lotion BId;
Also had meningitis vaccine.....body aches (hurt to walk or ride in vehicle) low fever to high fever of 103.8. Skin rash, severe headache, nausea, dizziness, sleeping constantly, dehydration, stomach pain wouldn't eat or drink hardly. Blood shot eyes.
Immense pain in Left Shoulder where injection was given, felt as if needle went into the shoulder bone, numbness and tingling to entire left arm. Ibuprofen 800 mg was taken and has been taken intermittently since date of shot. As of 11/29/12, still have pain at injection site, unable to life left arm to change clothes without pain 8-9 out of 10, unable to sleep on left side without pain in shoulder.
Right breast Cancer - diagnosed 6/18/22 on regular mammogram.  Upcoming lumpectomy, probable radiation and follow-up medications
This case was reported by a pharmacist via call center representative and described the occurrence of weakness of arms in a 74-year-old female patient who received SHINGRIX (batch number 9277N, expiry date unknown) for prophylaxis. On 29th January 2019, the patient received SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced weakness of arms and pain in arm. On an unknown date, the outcome of the weakness of arms and pain in arm were unknown. It was unknown if the reporter considered the weakness of arms and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on the left arm. The patient continued to have pain in the left arm, might be some weakness, when raising feels pain, pain seemed to be inside (not superficial, deeper in the tissue). The registered pharmacist did not had the expiry date of the vaccine. As per sales data sheet the batch number was changed from 9Z77N to 9277N.
Patient returned to the store to report pain, swelling and redness extending in a large area around the injection site. Inflamed area approx 5x5 inches. Pt reported treating with ibuprofen 200mg two Q 6 h. with pain persisting. Returned to store approx 23 hours after initial injection.
A pharmacist reported that an unidentified patient received a dose of Prevnar (penumococcal 7-valent conjugate vaccine) on (date not specified). "Within days" of vaccine administration, the patient developed localized cellulitis and possibly fever. MANUFACTURER'S COMMENT: The reporter indicated that over the past 2 months, 10 patients, aged 2-7 years of age experienced "localized cellulitis, some with fever, within days" of injection with a pneumococcal vaccine (manufacturer unknown). At the time of this report, all of the cases had resolved. No further information was available at the time of this report.
Hives; Is there a body rash with second doze of vaccine, I currently have a rash and it's just getting worse; Hypersensitivity reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), URTICARIA (Hives) and RASH (Is there a body rash with second doze of vaccine, I currently have a rash and it's just getting worse) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis, Hypersensitivity reaction and Hives (Hives/Urticaria). Concurrent medical conditions included Bee sting hypersensitivity (Bee's hypersensitivity).   On 10-Feb-2021 at 2:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021 at 5:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jun-2021 at 3:00 AM, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction). On an unknown date, the patient experienced URTICARIA (Hives) and RASH (Is there a body rash with second doze of vaccine, I currently have a rash and it's just getting worse). The patient was treated with LORATADINE (oral) ongoing from 19-Jun-2021 for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) ongoing from 19-Jun-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction) and URTICARIA (Hives) had resolved with sequelae and RASH (Is there a body rash with second doze of vaccine, I currently have a rash and it's just getting worse) outcome was unknown.            Treatment information were not provided by the reporter.  Concomitant medications were not reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 11-Aug-2021: Additional information included patient's demographics (height, weight) ethnic group, race, date of birth patient's allergies, second dose details, treatment and newevents.
T 104 /w unconsolable crying X 60 min, cranky X 48 hrs.
Moderna Covid -19 Vaccine EUA This morning I started having a fever, then 1 hour later chills and feeling fatigue. The sides of my body were soar and it was hard to get up. I feel a little disoriented and my arm is swollen and hurts.
Suspected vaccination failure; Now has glaucoma; Now broken out with shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included ankle operation (had major surgery on ankle 13 years ago from reporting date) and shingles (on face).   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), glaucoma (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the glaucoma and shingles were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, glaucoma and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The patient received new Shingles vaccine, last one months ago from the date of reporting and the patient had broken out with shingles on his back at the time of reporting. The patient now also had glaucoma. The patient asked if this Shingles shot did any good or was it just a money maker. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation of shingles were not provided.
Developed pain in the left deltoid muscle 1 day after the injection. Patient re-visited the pharmacy on  03/16/22 complaining of pain and soreness still present when moving the arm.
I had the shot on Friday, Oct 19th in the am- I went to turn over and got terrible pain in left chest-back and arm. Went to the hospital at 2:00 pm and was released from the hospital the following Tuesday at 2:00 pm.  01/02/2008 MR received for DOS 10/21-23/2007 with  dx chest pain likely costochondritis vs muscle strain. Pt initially noted sharp pain and pressure over L breast.  Pain radiated into L arm to elbow. Pain also noted in back and L side.  No other sx (SOB, diaphoresis, nausea etc) noted.  Pain improved with heat and Motrin.  PE (+) for tenderness to palpation along L breast and L lateral chest wall. (+) Alopecia x 1 yr, (+) dark pigmentation on cheekbones and under eyes. Dry mucous membranes.
Patient went to Dr. office & they administered 3rd dose H1N1 3 days after 2nd dose given at school health clinic.
Pt. had IZS 8-20-09, began wheezing by 10 p that eve - worsening by am 8-21-09.  Arrived for tx / received DUONEBXL plus 5 mg ALBUTEROL with unsatisfactory results.  No hx asthma.
Chest pain; Palpitations; Acute myocarditis; First dose in January, terrified to get the second dose; This spontaneous case was reported by a physician and describes the occurrence of CHEST PAIN (Chest pain), PALPITATIONS (Palpitations) and MYOCARDITIS (Acute myocarditis) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to metals and Drug allergy (Allergic to medications).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced CHEST PAIN (Chest pain) (seriousness criterion hospitalization), PALPITATIONS (Palpitations) (seriousness criterion hospitalization) and MYOCARDITIS (Acute myocarditis) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose in January, terrified to get the second dose). At the time of the report, CHEST PAIN (Chest pain), PALPITATIONS (Palpitations), MYOCARDITIS (Acute myocarditis) and PRODUCT DOSE OMISSION ISSUE (First dose in January, terrified to get the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant and treatment medications were reported.  Company Comment : This report refers to a case of product dose omission for mRNA-1273 (lot # unknown) with associated AE reported of myocarditis, palpitations and chest pain. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: This report refers to a case of product dose omission for mRNA-1273 (lot # unknown) with associated AE reported of myocarditis, palpitations and chest pain. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
have no appetite; was very weak; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (have no appetite), ASTHENIA (was very weak), HEADACHE (headache) and PYREXIA (fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Multiple sclerosis. Concomitant products included METFORMIN, CANAGLIFLOZIN HEMIHYDRATE, METFORMIN HYDROCHLORIDE (INVOKANA DUO) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DECREASED APPETITE (have no appetite), ASTHENIA (was very weak), HEADACHE (headache) and PYREXIA (fever). On 12-Mar-2021, DECREASED APPETITE (have no appetite), ASTHENIA (was very weak) and PYREXIA (fever) had resolved. On 14-Mar-2021, HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 100.7 (High) 100.7 degrees Fahrenheit.. On 12-Mar-2021, Body temperature: 98 (High) Rechecked next day, temperature decreased to 98 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Approximately 1 hour after receiving the vaccine: left back pain kidney area, them moved to front; chills fore hip bone 10/6/04 belly is hurting. Frequent BMS; feels much better
Two hours after the vaccine, I begun to have lightheadedness, poor concentration abilities .  The rash and itchiness of site injection that extended to the left side of face and left upper body onset  begun about 8: 00 pm.  I took a loratadine and 1 g of Tylenol.  Next day,  I woke up weak and experiencing some tachycardia, headache. I took 1 g of Tylenol at 8:00 am . About  10:30 I started feeling very weak and malaise, headache again , couldn't concentrate, and the lightheadedness was stronger at this time. Symptoms last about 48 hours.
1/19/2000, Pt rcv'd #3 dose of HEP-B. 1/25/00, pt had urticaria & tightness in the throat & chest. The urticaria worsened & th pt went to ER on 1/26/00.
Sore throat, pain at the injection sight, tiredness. She also had chills, headaches, fever, severe sinus. He appetite became decreasing, diarrhea, nausea and lightheadedness. All this took place over 48hrs.
TOOK FIRST DOSE OF VIVOTIF IMMEDIATELY AFTER EATING; This spontaneous case (PVX2019-1138) was received from a pharmacist on 07-May-2019. It describes a 34-year-old male consumer who "took first dose of Vivotif immediately after eating". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took the first dose of Vivotif immediately after eating on either 06-May-2019 or 07-May-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "took first dose of Vivotif immediately after eating" was unknown.  Company's Comment: The causality of the event "took first dose of Vivotif immediately after eating" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took first dose of Vivotif immediately after eating" was considered as not applicable.
Pt came to Kaiser to have injection site evaluated c/o redness and itchiness at site Td given yesterday. Right deltoid has area of induration 5" x 5 1/4". Warm to touch. Area erythematous.
Severe headache for two days, arm was very sore at injection site, but the armpit of arm that had injection was horribly painful and lymph nodes became very swollen and hard, also had a rash that extended from armpit down the whole side of body and across my belly.  (It took almost two weeks for swollen lymph nodes to return to normal.) Had severe chills (teeth chattering), stomach pain, dizziness, lightheaded, nauseous, and joint/ muscle pain.  Felt very wiped out for several days.
Pt received Pfizer COVID vaccine #1 on 6/26/21, and reported to the ED on 6/28 with chestpain (for 8 hours).  This pt had a LHC w/o INV on 6/28/21. He was discharged from the hospital on 6/30/21. A 30 day MCT was ordered today. The pt is scheduled for f/u w/ CFB on 8/4/21 at 1540 w/ a limited echo the same day.  Resulted in Hospitalization: 2 days.
Pt had IZ on 8/23/00 and had no adverse symptoms until waking on 8/24/00. He now has egg-sized area on his left arm that is edematous and tender to the touch, a small bruise at needle stick is also noted. No fever.
Headache, Fever, NauseaVomiting chills and sweats Narrative:
Patient called and stated that he had redness 5 inches long and 1 inch wide with the injection site at the center of the redness. The site was sore to touch. He received vaccine on 4/21/18 and redness was seen for first time on 4/22/18. He has no other reaction going on.
body aches, fatigue, headache, nausea, dizzy. Symptoms started on 1/25/2021. Admitted to the er on 1/28/21 with afib. Rhythm converted in the er